#CVPrev
It takes a village. A combined medical effort with community and family leadership focused on household diets, home monitoring, exercise, and treatment dropped SBP by > 10 mmHg more than usual care: https://bit.ly/4eiuWHU

#JACC #cvPrev #hypertension
November 3, 2026 at 6:05 PM
Can lifting weights + less TV lower heart risk? In a #JACC cohort of 117K women, aerobic exercise ≥15 MET-h/week + lifting ≥1 h/week + TV <2 h/day linked to 40% lower risk of major cardiovascular events.

More: https://bit.ly/4AoeqyL

#cvPrev #CardioSky
October 30, 2026 at 1:22 PM
Where is the sweet spot in cardiovascular inflammation? The goal: suppress harmful inflammation enough to reduce CV events while preserving defenses against infection & cancer. Can targeting inflammasomes or interleukin-6 strike that balance? Read on: https://bit.ly/4ika4Bf

#cvPrev #JACC #CardioSky
October 27, 2026 at 10:54 PM
Preventing the next cardiovascular event can be just as important as treating the first.

Explore practical, evidence-based approaches to secondary prevention in #NCDAcademy's latest course.

🔗 https://bit.ly/3Vsz0P1

#cvPrev #ACCPrev #CardioSky
October 23, 2026 at 8:14 PM
Discover the evidence, innovations & insights shaping CV medicine.

Join leading experts at #FusterCVS for 3️⃣ days of high-impact science exploring #cvPrev, coronary disease, #cvEP, #AI & more.

📍 Dec. 11-13 | NYC

View the agenda & register now ➡️ bit.ly/4h5ELex #CardioSky #ACCEd
October 21, 2026 at 5:26 PM
🧾 Evidence from clinical trials & real-world 📊 shows that vaccination can help reduce CV risks.

Explore the latest clinician & patient resources to support conversations about immunization & help your patients stay up to date w/ recommended vaccines. 🔗 https://bit.ly/4zaoOJD #cvPrev #CardioSky
October 16, 2026 at 1:43 PM
Can where people work reveal where #CVD prevention is most needed? New research presented at #GWICC/AHS 2026 & published in #JACC examines CV risk, treatment and control across China’s workforce, highlighting opportunities for #cvPrev.

Read the study: https://bit.ly/4yX16kq

#CardioSky #ACCIntl
October 16, 2026 at 11:45 PM
🆕 ACC Scientific Statement in #JACC:

A healthy dietary pattern matters more than any single nutrient or food for heart health. 🫀

🔗 Read more: https://bit.ly/4z5td0k

#cvPrev #ACCPrev #CardioSky @jaccjournals.bsky.social
September 30, 2026 at 2:17 PM
🆕 ACC Scientific Statement: A healthy, balanced dietary pattern, not individual nutrients or foods, is 🔑 to heart health. Emphasize minimally processed plant foods, healthy fats & proteins, while limiting refined starches, added sugars, sodium & unhealthy fats. https://bit.ly/46XHwYW #CVD #cvPrev
September 30, 2026 at 2:18 PM
This #WorldHeartDay, remember: prevention doesn't stop after a cardiovascular event. 🫀

🆕 #NCDAcademy course on Secondary Prevention in CV Disease helps clinicians reduce recurrent events & improve long-term outcomes through evidence-based care.

🔗 https://bit.ly/3Vsz0P1 #CardioSky #cvPrev #ACCPrev
September 29, 2026 at 4:15 PM
In a #JACCAdvances viewpoint, Ramzi Ibrahim, MD, reflects on the inaugural Fuster Prevention Forum and highlights its mission to equip clinicians to bring early prevention strategies back to their communities.

Read the full viewpoint ➡️ https://bit.ly/4jnVsTo #cvPrev #CardioSky
September 28, 2026 at 4:46 PM
🆕 #JACCAdvances viewpoint: Dr. Ramzi Ibrahim reflects on the inaugural Fuster Prevention Forum & calls for a shift toward #cvPrev before pts reach a cardiologist. With risk beginning in childhood, he highlights the potential of early prevention to add decades of healthy life https://bit.ly/4jnVsTo
September 28, 2026 at 3:21 PM
🆕 New in #CardiologyMag:
🔹 Antiplatelet therapy guidance for #ASCVD
🔹 DOAC guidance for preventing thrombotic events
🔹 Updated global HF definition to improve #cvPrev, diagnosis & treatment

Read the latest clinical guidance 👉 https://bit.ly/3V4ldOw

#JACC #CardioSky #ClinicalGuidelines
New in Clinical Guidance | Antiplatelets in ASCVD; DOACs in Preventing Thrombotic Events; Global HF Definition - American College of Cardiology
www.acc.org
September 21, 2026 at 7:27 PM
Better conversations lead to better care. Explore #CardioSmart’s multilingual infographic posters & decision aids, designed to help patients ask questions, understand options & make informed decisions with their care teams. https://bit.ly/4qAFBCs

#ACCIntl #ACCLATAM #cvPrev #CardioSky
September 18, 2026 at 9:20 PM
What if no one ever developed 🫀 disease? The Fuster Heart Movement is turning CV prevention into a 🌏 movement by training clinicians, empowering communities, & teaching children healthy habits that can last a lifetime. Learn more: https://bit.ly/4yAAXqS

#ACCLATAM #cvPrev #CardioSky
September 18, 2026 at 5:53 PM
Is the future of cardiovascular prevention treating risk factors, or detecting disease before symptoms begin? Hear from the esteemed Dr. Valentin Fuster and Dr. Ángel Alberto García Peña at #ACCLATAM this Friday! https://bit.ly/46nD2dU

#ACCIntl #cvPrev #CardioSky
September 18, 2026 at 12:18 AM
CV experts are gathering in Medellín for #ACCLATAM 2026 to share new science, practical education and strategies to improve 🌎 heart health. From disparities & #STEMI outcomes to #AI & #cvPrev, the future of CV care is on the agenda: https://bit.ly/4xwbJJy @sccccardio

#ACCIntl #CardioSky
September 17, 2026 at 5:30 PM
Late-breaking studies out of #ESCCongress highlight advances in dementia and triglyceride management. Read on: https://bit.ly/46vpNrp

#cvPrev #ACCIntl #Hypertension
August 30, 2026 at 8:49 PM
🫀 Prevention is 🗝️

Hear from Drs. Kusumoto and Mehta as they discuss the SHASTA-3/4 and CRHCP trials as ones watch from Hotline 9 at #ESCCongress in Munich.

Follow ACC's coverage here: https://bit.ly/4gAFan1

#ACCPrev #cvPrev #Dementia #BloodPressure #CardioSky
August 30, 2026 at 4:55 PM
REACT trial findings presented at #ESCCongress in Munich suggest use of imaging to detect silent atherosclerosis in early adulthood may help improve primary #cvPrev strategies and reduce the substantial burden of atherosclerotic CV disease.

Read more: https://bit.ly/4xCD3Xh
August 29, 2026 at 10:41 AM
Results from the STAREE trial presented at #ESCCongress found that atorvastatin lowered the risk of major CV events compared with placebo over ~6 years, though it did not extend disability-free survival.

Read more: https://bit.ly/4zPl6GA

#ACCIntl #cvPrev #CardioSky
August 29, 2026 at 9:12 AM
over my head
#cvprev #lipids #ldl-c #apob #cholesterol
but i can say keeping apo(b) at 60 for 30+yrs is a wise decision
Those with E4 alleles often have increased LDL-C (apoB) & CV risk are often statin hypo-responders. Reasons are: In E4 carriers, chylos trafficking absorbed cholesterol are rapidly cleared & the XS cholesterol, down-regulates LDL receptors & increases apoB. Cholesterol synthesis, is also decreased
March 24, 2025 at 1:51 AM
@drmarthagulati.bsky.social @erinmichos.bsky.social

i am thinking LDL particle number elevation, including elevated small particle number, will increase plaque formation still, 38yo female, exercises, normal weight, +family hx cvd

#cvprev #lipids #ldl-c #lipidology #womenshearthealth
March 14, 2025 at 4:31 PM